GlassScriptPhysician profile
William H Pasley
NPI 1740416239
$9,088.63
in general payments reported to CMS, 2019-2025
25 companies · $115 in 2025
The $115 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,757 · 2020: $135 · 2021: $313 · 2022: $190 · 2023: $277 · 2024: $4,301 · 2025: $115.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Long Term Medical Supply Or Device Loan: $3,938 · Food and Beverage: $756.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Long Term Medical Supply Or Device Loan | $3,938.05 |
| Food and Beverage | $755.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cashflow Solutions, LLC | $4,001.20 | 2024-2025 | Pcd-52 737a (US) White, Pcd-51 731a (US) - White, Lympha Press Optimal Plus(US) Bt |
| Medical Device Business Services, INC. | $1,674.99 | 2019 | |
| Intuitive Surgical, INC. | $1,487.30 | 2019-2021 | |
| Ethicon US, LLC | $517.04 | 2019-2023 | Monocryl, Linx Reflux Management System |
| Tactile Systems Technology INC | $368.53 | 2019-2024 | Flexitouch Plus, Entre Plus |
| Kci USA, INC. | $191.72 | 2022-2023 | V.A.C. Veraflo, V.A.C.Ulta, V.A.C. Dermatac |
| Davol INC. | $157.76 | 2023-2024 | Phasix Mesh |
| Tela Bio, INC. | $118.73 | 2024 | Ovitex 2s |
| Smith+Nephew, INC. | $112.49 | 2020-2025 | Renasys Touch, Oasis |
| Acell, INC. | $77.26 | 2019 | |
| Integra Lifesciences Corporation | $57.87 | 2019-2021 | |
| Organogenesis INC. | $46.82 | 2025 | Puraply Wound Matrix |
| Shire North American Group INC | $40.30 | 2019 | |
| Kerecis Limited | $37.19 | 2024-2025 | Kerecis Omega3 Marigen, Kerecis Surgiclose, Kerecis Omega3 Surgiclose |
| Mallinckrodt Enterprises LLC | $25.90 | 2019 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $20.19 | 2023 | Gattex |
| Solventum Corporation | $19.98 | 2024 | V.A.C. Granufoam |
| Baxter Healthcare | $19.40 | 2024 | Tisseel |
| Abbvie INC. | $17.95 | 2022 | |
| Medtronic, INC. | $17.72 | 2023 | Dextile |
| Tei Medical INC. | $17.51 | 2019 | |
| Biocomposites INC | $17.20 | 2021 | |
| Bioventus LLC | $16.36 | 2022 | |
| Teleflex LLC | $16.03 | 2024 | Titan Sgs |
| Allergan, INC. | $11.19 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Pasley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.